Harold Schaaff
@Soleus Capital Management, L.p.
Latest period2024 - Q3ReportedManaged Assets$1.291BTotal holdings87
Assets growth rate13.9%Assets growth rate (2-Q avg)-0.97%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Soleus Capital Management, L.p.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 87 positions.
Assets under management
The assets under management (AUM) of Soleus Capital Management, L.p. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.291B in assets, with a quarterly growth rate of 13.9% and a 2-quarter average growth rate of -0.97%. The portfolio is managed by Harold Schaaff, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
PENPenumbra Inc
| 0% | $22.217M 123,450 shares@ $179.98 avg price | Exited |
HUMHumana Inc
| 0% | $16.574M 44,356 shares@ $373.65 avg price | Exited |
TEVATeva Pharmaceutical Inds Ltd
| 0% | $9.531M 586,499 shares@ $16.26 avg price | Exited |
AVDLAvadel Pharmaceuticals Plc
| 0% | $7.157M 509,000 shares@ $14.06 avg price | Exited |
CVRXCvrx Inc
| 0% | $7.039M 587,098 shares@ $11.99 avg price | Exited |
HIMSHims & Hers Health Inc
| 0% | $6.723M 333,000 shares@ $20.19 avg price | Exited |
GMEDGlobus Med Inc
| 0% | $5.89M 86,000 shares@ $68.49 avg price | Exited |
JAZZJazz Pharmaceuticals Plc
| 0% | $5.756M 53,935 shares@ $106.74 avg price | Exited |
IRMDIradimed Corp
| 0% | $4.485M 102,067 shares@ $43.95 avg price | Exited |
EXASExact Sciences Corp
| 0% | $3.871M 91,611 shares@ $42.26 avg price | Exited |